Cargando…
Informed Decision-Making and Capabilities in Population-based Cancer Screening
Informed decision-making (IDM) is considered an important ethical and legal requirement for population-based screening. Governments offering such screening have a duty to enable invitees to make informed decisions regarding participation. Various views exist on how to define and measure IDM in diffe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883722/ https://www.ncbi.nlm.nih.gov/pubmed/36727101 http://dx.doi.org/10.1093/phe/phac023 |
_version_ | 1784879565474103296 |
---|---|
author | Bolt, Ineke L L E Schermer, Maartje H N Bomhof-Roordink, Hanna Timmermans, Danielle R M |
author_facet | Bolt, Ineke L L E Schermer, Maartje H N Bomhof-Roordink, Hanna Timmermans, Danielle R M |
author_sort | Bolt, Ineke L L E |
collection | PubMed |
description | Informed decision-making (IDM) is considered an important ethical and legal requirement for population-based screening. Governments offering such screening have a duty to enable invitees to make informed decisions regarding participation. Various views exist on how to define and measure IDM in different screening programmes. In this paper we first address the question which components should be part of IDM in the context of cancer screening. Departing from two diverging interpretations of the value of autonomy—as a right and as an ideal—we describe how this value is operationalized in the practice of informed consent in medicine and translate this to IDM in population-based cancer screening. Next, we specify components of IDM, which is voluntariness and the requirements of disclosure and understanding. We argue that whereas disclosure should contain all information considered relevant in order to enable authentic IDM, understanding of basic information is sufficient for a valid IDM. In the second part of the paper we apply the capability approach in order to argue for the responsibility of the government to warrant equal and real opportunities for invitees for IDM. We argue that additional conditions beyond mere provision of information are needed in order to do so. |
format | Online Article Text |
id | pubmed-9883722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98837222023-01-31 Informed Decision-Making and Capabilities in Population-based Cancer Screening Bolt, Ineke L L E Schermer, Maartje H N Bomhof-Roordink, Hanna Timmermans, Danielle R M Public Health Ethics Original Articles Informed decision-making (IDM) is considered an important ethical and legal requirement for population-based screening. Governments offering such screening have a duty to enable invitees to make informed decisions regarding participation. Various views exist on how to define and measure IDM in different screening programmes. In this paper we first address the question which components should be part of IDM in the context of cancer screening. Departing from two diverging interpretations of the value of autonomy—as a right and as an ideal—we describe how this value is operationalized in the practice of informed consent in medicine and translate this to IDM in population-based cancer screening. Next, we specify components of IDM, which is voluntariness and the requirements of disclosure and understanding. We argue that whereas disclosure should contain all information considered relevant in order to enable authentic IDM, understanding of basic information is sufficient for a valid IDM. In the second part of the paper we apply the capability approach in order to argue for the responsibility of the government to warrant equal and real opportunities for invitees for IDM. We argue that additional conditions beyond mere provision of information are needed in order to do so. Oxford University Press 2022-10-03 /pmc/articles/PMC9883722/ /pubmed/36727101 http://dx.doi.org/10.1093/phe/phac023 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Bolt, Ineke L L E Schermer, Maartje H N Bomhof-Roordink, Hanna Timmermans, Danielle R M Informed Decision-Making and Capabilities in Population-based Cancer Screening |
title | Informed Decision-Making and Capabilities in Population-based Cancer Screening |
title_full | Informed Decision-Making and Capabilities in Population-based Cancer Screening |
title_fullStr | Informed Decision-Making and Capabilities in Population-based Cancer Screening |
title_full_unstemmed | Informed Decision-Making and Capabilities in Population-based Cancer Screening |
title_short | Informed Decision-Making and Capabilities in Population-based Cancer Screening |
title_sort | informed decision-making and capabilities in population-based cancer screening |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883722/ https://www.ncbi.nlm.nih.gov/pubmed/36727101 http://dx.doi.org/10.1093/phe/phac023 |
work_keys_str_mv | AT boltinekelle informeddecisionmakingandcapabilitiesinpopulationbasedcancerscreening AT schermermaartjehn informeddecisionmakingandcapabilitiesinpopulationbasedcancerscreening AT bomhofroordinkhanna informeddecisionmakingandcapabilitiesinpopulationbasedcancerscreening AT timmermansdaniellerm informeddecisionmakingandcapabilitiesinpopulationbasedcancerscreening |